Professor Gavin Wilkinson
Prosiectau fel Prif Ymchwiliwr
- Analysis of cytomegalovirus pathogenesis in a human challenge system (01.04.2018 - 03.04.2023)
- An analysis of wild type human cytomegalovirus (01.12.2010 - 08.05.2014)
- A systematic investigation into human cytomegalovirus gene function (08.05.2014 - 31.12.2017)
- Development of a cytomegalovirus-based 5T4-expressing cancer vaccine (01.07.2015 - 30.06.2016)
- Development of adenovirus type 4 vectors for immunotherapeutic application (01.10.2008 - 31.01.2012)
Prosiectau fel Cyd-Ymchwiliwr
- Designing unconventional peptide modifications to universally enhance cd4+ t-cell activation (08.05.2018 - 08.05.2024)
- Developing HCMV as a vaccine vector (01.01.2014 - 31.12.2016)
- Developing HCMV as a vaccine vector (01.10.2017 - 31.10.2018)
- Development of adenovirus serotype 49 for cancer virotherapy applications (01.10.2015 - 30.09.2019)
- Development of anti-viral immunotherapy (01.10.2017 - 31.03.2018)